The National Cancer Institute (NCI) Center for Global Health announced grants that will support the development and validation of low-cost, portable technologies. These technologies have the potential to improve early detection, diagnosis, and noninvasive or minimally invasive treatment of several cancer types with a particularly high prevalence in low- and middle-income countries, noted Ted Trimble, MD, Director of the Center for Global Health. The researchers who received grants under the Center’s first major funding program will be incorporated in studies in India (oral cancers), Brazil (cervical cancer), Colombia (cervical neoplasia, or abnormal cell growth), South Africa (human papillomavirus [HPV] and cervical carcinoma), and the Philippines (cervical dysplasia).
As part of this program, the Center for Global Health has also partnered with the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health for one of the grants.
The grantees are: